文献速递胸部肿瘤放疗放疗物理与技术

质子束治疗技术对局部晚期肺癌患者肺毒性的预测:质子协作组前瞻性临床试验

Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2023-11-23

本研究分析了12家机构965例接受常规或轻度大分割质子束治疗的局部晚期肺癌患者,利用三种机器学习模型预测12个月内≥2级肺炎或呼吸困难。梯度提升模型表现最佳,组合人口学与剂量学特征后AUC为0.75±0.02,平衡准确度为0.67±0.02。笔束扫描、腹部压迫和呼吸屏气与较低毒性概率相关。

要点

  • 笔束扫描技术治疗的患者肺毒性概率为0.08,其他技术为0.34(P=8.97e-13)。
  • 腹部压迫和呼吸屏气是减少毒性的高度显著预测因子(P=2.88e-08)。
  • 梯度提升模型表现最佳,组合特征后AUC为0.75±0.02,平衡准确度为0.67±0.02。

主要发现

  • 250例(25.9%)发生≥2级肺毒性。
  • 笔束扫描治疗患者肺毒性概率为0.08,其他技术为0.34(P=8.97e-13)。
  • 腹部压迫和呼吸屏气是减少毒性的高度显著预测因子(P=2.88e-08)。
  • 较高的总辐射剂量(P=0.0182)和较高的同侧肺平均剂量(P=0.0035)增加肺毒性可能性。
  • 梯度提升模型表现最佳,组合人口学和剂量学特征后AUC为0.75±0.02,平衡准确度为0.67±0.02。

关键数值与推荐

  • 年龄中位数70岁(范围20-97),主要为IIIA或IIIB期疾病。
  • 中位剂量60 Gy,2 Gy/次,46.4%接受同步化疗。
  • 肺毒性定义为常见不良事件评价标准第4版≥2级肺炎或呼吸困难,发生在12个月内。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 分析性能与训练数据点数量后发现,准确度受观察数量限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to predict the probability of grade ≥2 pneumonitis or dyspnea within 12 months of receiving conventionally fractionated or mildly hypofractionated proton beam therapy for locally advanced lung cancer using machine learning. METHODS AND MATERIALS: Demographic and treatment characteristics were analyzed for 965 consecutive patients treated for lung cancer with conventionally fractionated or mildly hypofractionated (2.2-3 Gy/fraction) proton beam therapy across 12 institutions. Three machine learning models (gradient boosting, additive tree, and logistic regression with lasso regularization) were implemented to predict Common Terminology Criteria for Adverse Events version 4 grade ≥2 pulmonary toxicities using double 10-fold cross-validation for parameter hyper-tuning without leak of information. Balanced accuracy and area under the curve were calculated, and 95% confidence intervals were obtained using bootstrap sampling. RESULTS: The median age of the patients was 70 years (range, 20-97), and they had predominantly stage IIIA or IIIB disease. They received a median dose of 60 Gy in 2 Gy/fraction, and 46.4% received concurrent chemotherapy. In total, 250 (25.9%) had grade ≥2 pulmonary toxicity. The probability of pulmonary toxicity was 0.08 for patients treated with pencil beam scanning and 0.34 for those treated with other techniques (P = 8.97e-13). Use of abdominal compression and breath hold were highly significant predictors of less toxicity (P = 2.88e-08). Higher total radiation delivered dose (P = .0182) and higher average dose to the ipsilateral lung (P = .0035) increased the likelihood of pulmonary toxicities. The gradient boosting model performed the best of the models tested, and when demographic and dosimetric features were combined, the area under the curve and balanced accuracy were 0.75 ± 0.02 and 0.67 ± 0.02, respectively. After analyzing performance versus the number of data points used for training, we observed that accuracy was limited by the number of observations. CONCLUSIONS: In the largest analysis of prospectively enrolled patients with lung cancer assessing pulmonary toxicities from proton therapy to date, advanced machine learning methods revealed that pencil beam scanning, abdominal compression, and lower normal lung doses can lead to significantly lower probability of developing grade ≥2 pneumonitis or dyspnea.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Valdes G, Scholey J, Nano TF, et al. Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial. Int J Radiat Oncol Biol Phys. 2023. PMID: 38000701. doi:10.1016/j.ijrobp.2023.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。